Health Care & Life Sciences » Pharmaceuticals | Fuji Pharma Co. Ltd.

Fuji Pharma Co. Ltd. | Income Statement

Fiscal year is October-September. All values JPY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
25,174
29,215
31,680
34,229
35,387
37,909
Cost of Goods Sold (COGS) incl. D&A
14,695
17,498
19,471
21,404
21,388
22,704
Gross Income
10,479
11,717
12,209
12,825
13,999
15,205
SG&A Expense
7,218
8,544
8,958
9,256
9,684
10,814
EBIT
3,261
3,173
3,251
3,569
4,315
4,391
Unusual Expense
6
33
10
15
77
-
Non Operating Income/Expense
120
76
119
399
328
118
Interest Expense
55
50
37
35
34
38
Pretax Income
3,332
3,232
3,105
3,148
4,530
4,472
Income Tax
1,264
1,154
1,013
1,029
1,228
1,099
Consolidated Net Income
2,068
2,078
2,092
2,118
3,301
3,372
Net Income
2,068
2,078
2,092
2,118
3,301
3,372
Net Income After Extraordinaries
2,068
2,078
2,092
2,118
3,301
3,372
Net Income Available to Common
2,068
2,078
2,092
2,118
3,301
3,372
EPS (Basic)
73.24
70.24
68.77
70.80
110.30
112.67
Basic Shares Outstanding
28
30
30
30
30
30
EPS (Diluted)
73.23
70.24
68.77
70.80
110.30
112.67
Diluted Shares Outstanding
28
30
30
30
30
30
EBITDA
4,674
4,826
5,330
5,490
6,338
6,642

About Fuji Pharma Co.

View Profile
Address
Seito Kaikan, 6/F
Tokyo Tokyo 102
Japan
Employees -
Website http://www.fujipharma.jp
Updated 07/08/2019
Fuji Pharma Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products. Its services include medical care for women in vitro diagnostics, sale of acute medical care products and curative medicine (injection agents), and provides information regarding pharmaceuticals and healthcare. The company products include injection agents, internal drugs, drugs for external use, diagnostic agent, hormonal agent, cardiovascular preparation, antibiotic drugs, chemotherapeutic agent, genitourinary related drugs, dermatological preparation and others.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.